(E)-METHYL 3-(5-METHOXYPYRIDIN-3-YL)ACRYLATE, 95.0%, 1g

(3aR,6aR)-2,2-Dimethyl-3aH-cyclopenta[d][1,3]dioxol-4(6aH)-one, 95.0%, 10g

(S)-2,2-Dimethylcyclopropanecarboxylic acid, 95.0%, 1g

1-PHENYLIMIDAZOLIDIN-2-ONE, 95.0%, 250mg

2-Amino-4-methyl-nicotinonitrile, 95.0%, 25g

3,4,5-Trifluorophenyl trans,trans-4'-Propylbicyclohexyl-4-carboxylate>98.0%(GC)5g

H-lle-OH, 25g

5-Chloro-2-fluorobenzimidamide hydrochloride, 95.0%, 5g

2-Bromo-4-fluoro-1-(methylthio)benzene, 95.0%, 250mg

3',6'-Dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-5-carboxylic acid, 95.0%, 5g

Quinoxaline, 5-(bromomethyl)-, 95%, 250mg

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-inden-1-one, 97%, 5g

N-(3-(Trifluoromethyl)benzyl)ethanamine, 95.0%, 5g